Frazier Healthcare Partners is a private equity and venture capital firm specializing in Growth buyout investment specifically targets businesses that deal Healthcare, Life Sciences, Pharmaceutical services, medical products, and related sectors. Frazier Healthcare Partners was formed in 1991 and is based in Seattle, Washington with an additional office in Palo Alto, California; Boston, Massachusetts; and Menlo Park, California.
Join Mergr to view the latest updates and news from Frazier Healthcare Partners.
In the last 3 years, Frazier Healthcare Partners has acquired 2 companies. It has also invested in 1 other.
Frazier Healthcare Partners’ most common sectors for investment are healthcare services (39%) and life science (24%). The Firm’s most common investment types include buyout (lbo, mbo, mbi) (31%) and venture (24%). In total, Frazier Healthcare Partners has invested in 8 US states and 2 different countries.
In the last 3 years, Frazier Healthcare Partners has exited 1 company. The Firm’s most common exit type is trade sale (67%). Frazier Healthcare Partners’ largest (disclosed) exit occurred in 2016 when it sold PCI Pharma Services for $1.0B.
Join Mergr to view Frazier Healthcare Partners’ full profile and discover more large private equity firms just like it.
No obligation. Cancel anytime.